RHO and cancer: The abnormally stiff ECM in advanced cancers then induces abnormal Rho-ROCK pathway-mediated cellular contractility with increased isometric tension, and with chronic activation of the MAPK-ERK (proto) oncogenic pathway, all of which are necessary to maintain an invasive phenotype of cancer cells [6, 8, 11].